tiprankstipranks
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market
Holding TRAW?
Track your performance easily

Traws Pharma (TRAW) Financial Statements

1,829 Followers

Traws Pharma Financial Overview

Traws Pharma's market cap is currently ―. The company's EPS TTM is $-141.345; its P/E ratio is ―; Traws Pharma is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-9.55. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 57.00K$ 57.00K$ 56.00K$ 57.00K$ 57.00K
Gross Profit$ 57.00K$ 57.00K$ 56.00K$ 57.00K$ 57.00K
EBIT$ -8.47M$ -123.14M$ -4.98M$ -5.09M$ -4.25M
EBITDA$ -8.47M$ -123.14M$ -4.98M$ -5.08M$ -4.25M
Net Income Common Stockholders$ -8.47M$ -123.14M$ -4.98M$ -4.74M$ -4.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 8.94M$ 18.69M$ 18.17M$ 27.04M$ 30.47M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 10.97M$ 12.59M$ 12.16M$ 12.52M$ 11.57M
Stockholders Equity$ -2.03M$ -105.52M$ 6.01M$ 14.52M$ 18.90M
Cash Flow-
Free Cash Flow$ -11.48M$ -13.50M$ -4.42M$ -4.48M$ -4.49M
Operating Cash Flow$ -11.48M$ -9.85M$ -4.42M$ -4.47M$ -4.49M
Investing Cash Flow-$ -3.65M-$ -14.00K-
Financing Cash Flow-$ 14.00M---
Currency in USD

Traws Pharma Earnings and Revenue History

Traws Pharma Debt to Assets

Traws Pharma Cash Flow

Traws Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis